"Quite obvious with otc listing and no news for ages that something big is coming"
... Or perhaps the honeymoon period is over? Do current / potential shareholders want to see some real sales traction rather than more great announcements that do not bear fruit?
"They were pumping out 1 announcement a week last year"
Again, same comment as above. All those distribution partnerships in hearing / optical channels, the buzz about LiveIQ that was to ship in Q4, HSP, and as you say, NHS and Specsavers. Actual delivery on any of these less than overwhelming (in my opinion)
Announces partnership with ams AH for LiveIQ ANC chip 10/01/2018 1 Announces sales orders of 16,652 units shipped in calendar 2017 1/02/2018 2 Retail - Distribution partnership - Puretone, Oaktree (US), PC Werth (UK) 8/02/2018 3 Retail - 3 mth retail trial with Hearing Planet & Connect Hearing (Aust) 14/02/2018 4 EAR-ID (NAL-NL2) receives clinical validation 22/02/2018 5 Retail - Acuitis launches IQ Buds across 66 B&M's 23/02/2018 6 Boost production starts - taking pre-orders 26/02/2018 7 HSP announcement 16/03/2018 8 R&D Tax Rebate ($1.2M) 18/04/2018 9 Boost commences shipping 24/04/2018 10 Retail - 'Best Buy' - Boosts to be featured in 'Senior Tech' catagory 15/05/2018 11 Retail - Distribution partnership - Force (Aust) 30/05/2018 12 Retail - Distribution partnership - ValueTrade (Japan) 31/05/2018 13 CR - $6M @ 9.5c per share (63.2M new ordinary shares) 8/06/2018 14 LiveIQ production update (for engineering validation) 27/06/2018 15 MO resignation 4/07/2018 16 Announces initial sell through of 2500 Boosts (pre-orders) 19/07/218 17 Retail - partners with Quantum Networks for Amazon sales 20/08/2018 18 Farjoy takes on MO holding (23.3M shares) 28/08/2018 19 Retail - Distribution partnership - ADCO (US) - for Boosts 5/09/2018 20 Retail - Vision Ottica (Italy) - 50 store trial of Boosts 18/09/2018 21 Investor update presentation - Max, TV streamer, new sales focus 1/10/2018 22 Bose Hearing Aid - FDA approval - De Novo status 17/10/2018 23 R&D Tax Rebate ($1.9M) 23/10/2018 24 Q3 cash flow results announced - $661k in receipts 31/10/2018 25 Retail - Hidden Hearing (Ireland) - 61 clinics from Dec 1st 22/11/2018 26 NHS announcement - Boost to be placed on NHS approved supplier list 28/11/2018 27 CR - $5M @ 7.5c per share (66.6M new ordinary shares) 4/12/2018 28 Specsavers to trial Boosts and touchpoint - Worthing UK store 17/12/2018
- Forums
- ASX - By Stock
- NUH
- nuh media thread
nuh media thread, page-9151
-
- There are more pages in this discussion • 6,496 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NUH (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.91M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NUH (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online